Zenotech Laboratories Ltd Experiences Surge Amid Broader Market Decline and Sector Resilience
2025-04-03 14:20:09Zenotech Laboratories Ltd is currently witnessing significant buying activity, with the stock surging by 9.99% today, contrasting sharply with the Sensex's decline of 0.41%. Over the past week, Zenotech has recorded a robust gain of 15.45%, while the Sensex has fallen by 1.68%. Notably, the stock has been on a positive trajectory for the last three days, accumulating a total return of 17.31% during this period. The stock reached an intraday high of Rs 61, reflecting a 9.24% increase. In terms of moving averages, Zenotech's current price is above its 5-day, 20-day, and 50-day averages, although it remains below the 100-day and 200-day averages. This performance indicates a short-term bullish trend amidst a broader market context. The Pharmaceuticals & Drugs sector has also shown resilience, gaining 2.2% today, which may contribute to the buying pressure on Zenotech. Despite its recent gains, the stock's ye...
Read More
Zenotech Laboratories Faces Market Challenges Amid Declining Stock Performance and Bearish Indicators
2025-03-13 15:06:36Zenotech Laboratories, a microcap in the Pharmaceuticals & Drugs sector, is nearing a 52-week low, trading below key moving averages and underperforming its sector. Despite a modest growth in net sales and operating profit over five years, the company's long-term growth prospects appear challenging amid a bearish market outlook.
Read More
Zenotech Laboratories Faces Market Volatility Amid Concerns Over Long-Term Growth Prospects
2025-03-05 09:45:20Zenotech Laboratories has reached a new 52-week low amid notable market activity, despite a slight recovery during the day. The company has shown consecutive gains recently but faces challenges with slow long-term growth, underperforming in one-year metrics compared to the benchmark Sensex, while maintaining a conservative financial structure.
Read More
Zenotech Laboratories Faces Long-Term Growth Challenges Despite Recent Stock Volatility
2025-03-05 09:45:17Zenotech Laboratories, a microcap in the Pharmaceuticals & Drugs sector, hit a new 52-week low today but experienced some recovery. Despite recent gains, the company's long-term outlook is concerning, with a significant decline in one-year performance and modest growth in key financial metrics.
Read More
Zenotech Laboratories Hits 52-Week Low Amid Broader Market Gains and Sector Resilience
2025-02-19 10:05:26Zenotech Laboratories has reached a new 52-week low, reflecting a significant decline over the past year compared to the broader market. Despite this, the company has shown short-term resilience, outperforming its sector recently and achieving modest gains over the last two days, although it remains below key moving averages.
Read More
Zenotech Laboratories Reports Q3 FY24-25 Results, Highlights Mixed Financial Trends
2025-01-28 17:34:35Zenotech Laboratories has announced its financial results for Q3 FY24-25, reporting net sales of Rs 11.24 crore, the highest in five quarters. Profit Before Tax reached Rs 2.12 crore, showing growth compared to previous quarters, while Profit After Tax for the half-year declined significantly year on year.
Read MoreAnnouncement under Regulation 30 (LODR)-Change in Directorate
30-Mar-2025 | Source : BSECompletion of tenure of Smt. Kavita Rakesh Shah Independent Director of the Company
Closure of Trading Window
26-Mar-2025 | Source : BSEIntimation of Trading Window Closure.
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
15-Mar-2025 | Source : BSEResult of the Postal Ballot by Remote e-Voting process and submission of Scrutinizers Report dated March 15 2025
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Zenotech Laboratories Ltd has announced 17:22 rights issue, ex-date: 01 Jun 17